Pfizer to Spend $120 Million to Boost U.S. COVID Pill Manufacturing

Pfizer Inc (PFE.N) said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up. That sounds like a great investment!

Read more about it

Photo Credit: Alexander Mils